0.3253

5.71% -0.0197

After Hours: .33 0.0047 +1.44%

Adial Pharmaceuticals Inc (ADIL)

Overview News Price History Financials Why ADIL Down? Discussions Forecast Stock Split

Adial Pharmaceuticals Inc stock is traded at $0.3253, with a volume of 430.59K. It is down -5.71% in the last 24 hours and down -18.35% over the past month. Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.

Previous Close:

$0.345

Open:

$0.331

24h Volume:

430.59K

Relative Volume:

0.64

Market Cap:

$7.10M

Revenue:

Net Income/Loss:

$-6.07M

P/E Ratio:

-0.0563

EPS:

-5.78

Net Cash Flow:

$-7.34M

1W Performance:

-13.80%

1M Performance:

-18.35%

6M Performance:

-51.45%

1Y Performance:

-67.63%

1-Day Range:

$0.325

$0.347

1-Week Range:

$0.325

$0.372

52-Week Range:

$0.22

$1.30

Adial Pharmaceuticals Inc Stock (ADIL) Company Profile

Name

Adial Pharmaceuticals Inc

Sector

Healthcare (1135)

Industry

Biotechnology (633)

Phone

434-422-9800

Address

1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA

Employee

Twitter

@AdialPharma

Next Earnings Date

2024-12-12

Latest SEC Filings

ADIL's Discussions on Twitter

Compare ADIL with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ADIL Adial Pharmaceuticals Inc	0.3253	7.53M	0	-6.07M	-7.34M	-5.78
VRTX Vertex Pharmaceuticals Inc	421.67	109.22B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	628.00	67.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	423.47	57.35B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	831.48	50.87B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	182.77	39.72B	447.02M	-1.18B	-868.57M	-6.1812

Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-14-24	Initiated	Rodman & Renshaw	Buy
Oct-30-18	Initiated	Maxim Group	Buy
Oct-11-18	Initiated	Dawson James	Buy

Adial Pharmaceuticals Inc Stock (ADIL) Latest News

Nov 03, 2025

Should I hold or sell Adial Pharmaceuticals Inc. stock in 2025July 2025 PostEarnings & High Return Trade Opportunity Guides - newser.com

Nov 03, 2025

Real time social sentiment graph for Adial Pharmaceuticals Inc.Watch List & Trade Opportunity Analysis Reports - newser.com

Nov 03, 2025

Will Adial Pharmaceuticals Inc. stock continue upward momentum2025 Geopolitical Influence & High Accuracy Investment Signals - newser.com

Nov 03, 2025

Will Adial Pharmaceuticals Inc. stock benefit from infrastructure spendingMarket Trend Summary & Free Expert Approved Momentum Trade Ideas - newser.com

Nov 03, 2025

What high frequency data says about Adial Pharmaceuticals Inc.July 2025 PostEarnings & Stepwise Entry and Exit Trade Signals - newser.com

Nov 03, 2025

Heatmap analysis for Adial Pharmaceuticals Inc. and competitorsWeekly Trade Recap & Weekly Hot Stock Watchlists - newser.com

Nov 03, 2025

Why analysts upgrade Adial Pharmaceuticals Inc. stockJuly 2025 Sector Moves & Breakout Confirmation Trade Signals - newser.com

Nov 03, 2025

Has Adial Pharmaceuticals Inc. formed a bullish divergenceTrade Analysis Report & Low Drawdown Investment Strategies - newser.com

Nov 03, 2025

Forecasting Adial Pharmaceuticals Inc. price range with options dataEarnings Recap Report & AI Driven Stock Reports - newser.com

Nov 03, 2025

Nov 02, 2025

Is this a good reentry point in Adial Pharmaceuticals Inc.Market Risk Summary & Daily Entry Point Trade Alerts - newser.com

Nov 02, 2025

Nov 01, 2025

How hedge fund analytics apply to Adial Pharmaceuticals Inc. stockQuarterly Profit Summary & Safe Capital Growth Stock Tips - newser.com

Nov 01, 2025

Oct 31, 2025